WebCareHealth, a leading remote patient monitoring platform for Home INR Management is proud to provide timely solutions to those affected by the current national shortage of blue top collection tubes containing sodium citrate, which is used primarily for coagulation testing.
As pathologists and laboratories across the country continue to report critical sodium citrate shortages, the FDA has recommended implementing conservation strategies to deal with continued supply challenges, which are expected to last until mid-Summer 2021.
“Coagulation testing is critical to help patients avoid the risk of stroke, major bleeds, and even death. The national shortage of testing supplies poses a serious threat to hospitals, health systems, and physician practices who are the point of care for patients on anticoagulation therapy for atrial fibrillation, mechanical heart valves, previous deep vein thrombosis, and more, said Dr. Teresa Sieck, CEO, and President, WebCareHealth.
CoagMgr from the WebCareHealth platform is a unique streamlined, web-based model for managing INR (International Normalized Ratio) patients at home. INR testing is required for patients on certain anticoagulation medications. It is designed so health care providers can work directly with patients to more easily monitor and adjust dosages in real-time.
After self-testing, patients submit their INR results directly via mobile app, web, or via phone. CoagMgr offers real-time results to physicians so they are able to take appropriate clinical action.
“WebCareHealth recognizes the current need for urgent solutions and is committed to relieving this crisis by offering our safe in-home INR testing approach, CoagMgr. We will continue to monitor this critical situation and remain available to help health care providers deliver the best possible care for their patients,” said Dr. Sieck.